Delivering quality therapy since 1901

Announcements

 

 

Annual General Meeting 2019 - Proposal, draft resolutions, PoA draft, voting rights2051<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.000000000002019-04-01T22:00:00Z4/2/2019 7:39:54 AM798http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Composition of share capital and voting rights2022<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.000000000002019-03-31T22:00:00Z4/1/2019 1:10:09 PM58http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Extraordinary announcement2018<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.000000000002019-03-25T23:00:00Z3/26/2019 8:14:51 AM1132http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Annual General Meeting 2019 - Invitation and Remuneration statement2015<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.000000000002019-03-21T23:00:00Z3/22/2019 8:33:16 AM1237http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Composition of share capital and voting rights 1972<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.000000000002019-02-28T23:00:00Z3/1/2019 4:05:09 PM153http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Extraordinary Announcement1974<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.000000000002019-02-28T23:00:00Z3/1/2019 6:43:01 PM1595http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Richter and Allergan expanded their distribution and supply agreement for Levosert to Latin America1895<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.00000000000<p><strong>​</strong><span lang="EN-US"><strong>Gedeon Richter Plc. (hereinafter&#58; “Richter”) today announced that it has entered into a distribution and supply agreement with a wholly owned subsidiary of Allergan plc (hereinafter&#58; “Allergan”) to commercialize its levonorgestrel releasing Intrauterine System (IUS) in Latin American countries. The product is already marketed by Richter under the trademark of Levosert<sup>TM</sup> since 2011 in most of Europe through agreements established with Allergan.</strong></span></p>2019-02-11T23:00:00Z2/12/2019 7:35:31 AM299http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Richter Group Report - 12 Months to December 20181952<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.000000000002019-02-06T23:00:00Z2/7/2019 8:32:51 AM2320http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Extraordinary Announcement1956<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.000000000002019-02-06T23:00:00Z2/7/2019 5:06:52 PM2114http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Richter and Pantarhei signed a license and supply agreement for commercialisation of a novel combined oral contraceptive1925<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.00000000000<p>​Gedeon Richter Plc. (hereinafter&#58; &quot;Richter&quot;) and Pantarhei Bioscience BV (hereinafter&#58; &quot;Pantarhei&quot;) today announced that they have entered into a license and supply agreement to commercialise Pantarhei's combined oral contraceptive (COC), containing 30 µg ethinyl estradiol, 150 µg levonorgestrel and 50 mg dehydroepiandrosterone (DHEA). The product is under development with successfully completed Phase II trials and is ready for further clinical studies to obtain marketing approval. The geographic scope of the agreement covers Europe, Russia, Latin America and Australia.</p>2019-02-03T23:00:00Z2/4/2019 7:13:54 AM294http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx